Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy

Our recent findings strongly support the idea of PLAC1 being as a potential immunotherapeutic target in prostate cancer (PCa). Here, we have generated and evaluated an anti-placenta-specific1 (PLAC1)-based antibody drug conjugate (ADC) for targeted immunotherapy of PCa. Prostate cancer cells express...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Rep
Egile Nagusiak: Nejadmoghaddam, Mohammad-Reza, Zarnani, Amir-Hassan, Ghahremanzadeh, Ramin, Ghods, Roya, Mahmoudian, Jafar, Yousefi, Maryam, Nazari, Mahboobeh, Ghahremani, Mohammad Hossein, Abolhasani, Maryam, Anissian, Ali, Mahmoudi, Morteza, Dinarvand, Rassoul
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5645454/
https://ncbi.nlm.nih.gov/pubmed/29042604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-13682-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak